In-Vitro Diagnostic Substance Manufacturing

NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) encompasses the production of specialized diagnostic reagents, test kits, and related substances used for medical testing and research. These products are designed to detect, measure, or identify specific biological markers, pathogens, genetic variations, and other clinical indicators in human specimens. The category includes manufacturers developing molecular diagnostic panels, immunoassay reagents, genetic testing kits, and other sophisticated laboratory diagnostic substances that support clinical testing, medical research, and healthcare diagnostics.

Federal contract awards in this category frequently involve procurement of diagnostic testing equipment, reagents, and consumables for federal medical facilities, with typical contract values ranging from $10,000 to over $1.5 million. The Department of Veterans Affairs, National Institutes of Health, Indian Health Service, and Defense Health Agency are the most common funding agencies. Frequently awarded entities include Biomerieux, Roche Diagnostics, Cepheid, Abbott Laboratories, and Qiagen. Most awards are not set aside, though some feature Service-Disabled Veteran-Owned Small Business or Buy Indian Act designations. Performance locations are predominantly federal medical centers and research facilities across the United States, with contract durations typically spanning one to five years.

Recent federal contract opportunities focus on comprehensive laboratory diagnostic solutions, including molecular testing platforms, specialty reagent kits, and advanced diagnostic equipment. Solicitations cover diverse testing needs such as microbiology screening, hematology analyzers, urinalysis systems, genetic sequencing, and specialized pathogen detection. Key federal agencies requesting these technologies include the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense medical facilities. Performance locations are concentrated in military medical centers, VA healthcare systems, and federal research institutions, with most opportunities seeking full and open competition and emphasizing technical capabilities, FDA approvals, and comprehensive testing methodologies.